During Monday’s current trade, The Dow Chemical Company (NYSE:DOW)’s shares gained 1.41%, and is now trading at $48.92, as on last Thursday, Dow AgroSciences, a wholly owned partner of The Dow Chemical Corporation (DOW), and Radiant Genomics declared a research and development (R&D) partnership contract to discover novel natural products for application in crop protection products. The partnership combines proprietary metagenomic and engineering-biology technologies from Radiant Genomics with Dow AgroSciences’ industry-leading natural products discovery and product development capabilities to deliver new products from naturally derived chemistries.
“This partnership will allow us to combine the expertise and capabilities within Dow AgroSciences with Radiant’s proprietary technologies to accelerate our industry-recognized natural products discovery program, building on our commitment to sustainable solutions,” said Daniel R. Kittle, Vice President of Research and Development at Dow AgroSciences.
The technology employed by Radiant Genomics will enhance Dow AgroSciences’ natural product lead generation and optimization process. Working together, the combined expertise can assist to bring new crop protection products to the
The Dow Chemical Corporation manufactures and supplies products that are used primarily as raw materials in the manufacture of customer products and services worldwide.
Johnson & Johnson (NYSE:JNJ)’s shares declined -0.27% during the current trading session Monday, and is now trading at $99.37, as Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, on last Thursday, declared that it has accomplished the divestiture of its U.S. license rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) oral solution to Depomed for $1.05 billion.
JPI’s licensed U.S. commercialization rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) oral solution from Grunenthal GmbH were assigned to Depomed. JPI will retain license rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) oral solution in Canada, Japan, and a number of other countries outside the United States.
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
During current trade, Newmont Mining Corporation (NYSE:NEM)’s shares climbed 1.30%, and is now trading at $22.63, as Newmont Mining Corporation, today recently published its 2014 sustainability report, Beyond the Mine, detailing the Corporation’s safety, economic, environmental and social performance, in addition to its commitment to ethical business practices.
The report reflects Newmont’s reporting obligations as a founding member of the International Council on Mining and Metals (ICMM), in addition to its commitments under the Voluntary Principles on Security and Human Rights (VPSHR) and the United Nations Global Compact. Newmont reports its sustainability performance against the Global Reporting Initiative’s (GRI) sustainability reporting framework – a comprehensive set of indicators covering sustainable development – and is independently assured.
Highlights from the 2014 report comprise:
- Achieving the lowest injury rate in Newmont’s history for the second year in a row; however, two fatalities at Newmont’s operations in Ghana demonstrate that the Corporation’s work to achieve a culture of zero harm never ends;
- Publishing an independently assured, Conflict-Free Gold Report confirming Newmont does not operate in areas classified as “conflict-affected or high risk” and is in conformance with the criteria established by the World Gold Council’s Conflict-Free Gold Standard;
- Gaining approval to expand underground mining operations in Waihi, New Zealand through a comprehensive public involvement program;
- Establishing the Newmont Akyem Development Foundation (NAkDeF) at the Corporation’s newest operation; NAkDeF has a similar structure to the Newmont Ahafo Development Foundation, which was recognized in 2014 as the best social influence investment vehicle in Africa by the European Union’s African Chamber of Commerce;
- Receiving the government of Indonesia’s first-ever botanical garden designation at a reclaimed, former mine site;
- Implementing a global water strategy to more effectively manage and mitigate water risks and more clearly link water administration practices with long-term planned and social responsibility objectives; and
- Demonstrating a commitment to transparency through the development of external targets for complaints and grievances, water administration, and closure and reclamation.
Newmont Mining Corporation operates in the mining industry. It primarily attains, develops, explores for, and produces gold, copper, and silver deposits. The corporations operations and/or assets are located in the United States, Australia, Peru, Indonesia, Ghana, and New Zealand.
Huntington Bancshares Incorporated (NASDAQ:HBAN), during its Monday’s current trading session gained 0.27%, and is now trading at $11.07, as on last Wednesday, accomplished its attainment of Michigan-based Macquarie Equipment Finance, Inc. (MEF-US) from its parent corporation, Sydney, Australia-based Macquarie Group Ltd. The attainment is predictable to be accretive to Huntington’s earnings in 2015.
MEF-US is the largest standalone, independent provider of specialized technology financing in North America with about $500 million of annual originations. With recently’s declarement, MEF-US will start transitioning to operate under the name Huntington Technology Finance. Based outside of Detroit, MEF-US is the sixth major investment Huntington has made in Michigan in the past five years.
The transition will be seamless for customers who will continue to interface with the converting MEF-US workforce, under the ongoing leadership of Gregory Goldstein, formerly president of MEF-Global. The attainment will add more than 165 jobs to Huntington’s colleague base.
Under the terms of the contract, Huntington attaind about $900 million of assets and assumed about $630 million of debt, securitizations, and other liabilities.
Huntington Bancshares Incorporated operates as a holding corporation for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
